Kapspargo Sprinkle Available to Treat Hypertension, Angina, Heart Failure

Kapspargo Sprinkle is the first extended-release sprinkle formulation of metoprolol succinate

Sun Pharma announced the availability of Kapspargo Sprinkle (metoprolol succinate extended-release) for the treatment of hypertension in patients aged ≥6 years; for long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance; and to reduce the risk of cardiovascular mortality and heart failure hospitalization in patients with heart failure.

Leave a Reply

Your email address will not be published. Required fields are marked *